GSK (NYSE: GSK) president adds notional ADS via savings plan

Rhea-AI Filing Summary

GSK plc reported a routine executive share transaction involving President Maya Martinez-Davis. She acquired notional American Depositary Shares (ADS) within her GSK Executive Supplemental Savings Plan account. The transaction covered 8.572 ADS at a price of $55.7000 per ADS on 2026-04-22 on the New York Stock Exchange.

Key Figures

ADS volume acquired: 8.572 ADS ADS price: $55.7000 per ADS Transaction date: 2026-04-22 +1 more

4 metrics

ADS volume acquired 8.572 ADS Notional ADS in Executive Supplemental Savings Plan

ADS price $55.7000 per ADS Price for notional acquisition on 2026-04-22

Transaction date 2026-04-22 Date of notional ADS acquisition

Trading venue New York Stock Exchange (XNYS) Listed place of the transaction

Key Terms

American Depositary Shares, Executive Supplemental Savings Plan, PDMR, ISIN, +1 more

5 terms

American Depositary Shares financial

"Description of the financial instrument | American Depositary Shares ('ADS')"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Executive Supplemental Savings Plan financial

"Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account."

PDMR regulatory

"Details of PDMR/person closely associated with them ('PCA')"

A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.

ISIN financial

"American Depositary Shares ('ADS') ISIN: US37733W2044"

A 12-character International Securities Identification Number (ISIN) is a unique code that acts like a passport for a specific stock, bond or other tradable security so it can be identified worldwide. Investors and systems use it to ensure they are buying, selling and tracking the exact same instrument across exchanges and data feeds, which prevents costly mix-ups and makes portfolio reporting, settlement and regulatory checks simpler and more reliable.

LEI regulatory

"Name | GSK plc b) | LEI | 5493000HZTVUYLO1D793"

A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

​

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Maya Martinez-Davis
b)	Position/status	President, US
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		$55.7000	8.572
d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2026-04-22
f)	Place of the transaction	New York Stock Exchange (XNYS)

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: April 24, 2026

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc

FAQ

What insider transaction did GSK (GSK) disclose in this Form 6-K?

GSK disclosed that President Maya Martinez-Davis acquired notional American Depositary Shares within her GSK Executive Supplemental Savings Plan account, reflecting a routine compensation-related transaction rather than an open-market trade by the executive personally.

How many GSK (GSK) ADS did Maya Martinez-Davis acquire and at what price?

Maya Martinez-Davis acquired 8.572 notional American Depositary Shares at a price of $55.7000 per ADS, recorded as part of her participation in the GSK Executive Supplemental Savings Plan rather than a standard cash stock purchase.

When and where was the GSK (GSK) ADS transaction executed?

The notional ADS acquisition for Maya Martinez-Davis’s plan account took place on 2026-04-22. The reference market for the transaction was the New York Stock Exchange, recorded under the venue code XNYS in the disclosure.

What type of financial instrument was involved in the GSK (GSK) executive transaction?

The transaction involved American Depositary Shares, identified by ISIN US37733W2044. These ADS represent GSK equity and are used within the Executive Supplemental Savings Plan as a notional measure tied to the company’s share performance.

Is the GSK (GSK) disclosed transaction an open-market trade or a plan-related acquisition?

The transaction is described as an acquisition of notional ADS within the GSK Executive Supplemental Savings Plan account, indicating a plan-related, compensation-style entry rather than a discretionary open-market stock trade by the executive.